Ledger.Open graph →
SEC Form D · filed April 11, 2016

Vividion Therapeutics, Inc

Offering
$4.0M
Sold
$3.5M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
PRINCETON, NJ
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (9)

Benjamin K. Cravatt · Princeton, NJDirectorJohn K. Clarke · Princeton, NJExec · DirectorJohn K. Park · Princeton, NJExec · DirectorJeffrey G. Galentine · Columbia, MDExec · DirectorEnterprise Fund Manager II, LLC · Columbia, MDDirectorEnterprise Community Investment, Inc · Columbia, MDExec · DirectorScott J. Nolan · San Francisco, CAExec · DirectorFrank J. Costa, Md · Harmony, PAExec · DirectorAnthony J. Tomasello · Harmony, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗